Literature DB >> 2597680

Identification of a human ribosomal protein mRNA with increased expression in colorectal tumours.

K A Chester1, L Robson, R H Begent, I C Talbot, J H Pringle, L Primrose, A J Macpherson, G Boxer, P Southall, A D Malcolm.   

Abstract

A human ribosomal protein cDNA was selected from a normal colon cDNA library on the basis of overexpression in familial adenomatous polyposis. Nucleotide sequence analysis was used to identify this cDNA as corresponding to the human equivalent of the rat ribosomal protein L31 (HL31). We have quantified the expression of HL31 mRNA in colorectal tumours and found overexpression in 23 out of 23 cases. Our results indicate that HL31 is associated with a malfunction of normal growth regulatory mechanisms in these tumours, and suggest a role for HL31 in proliferation and neoplasia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2597680     DOI: 10.1016/0167-4781(89)90119-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress.

Authors:  T Tanaka; S Kondo; Y Iwasa; H Hiai; S Toyokuni
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

2.  Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein.

Authors:  K Pogue-Geile; J R Geiser; M Shu; C Miller; I G Wool; A I Meisler; J M Pipas
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Decreased expression of ribosomal proteins in human age-related cataract.

Authors:  WeiYan Zhang; John Hawse; QingLing Huang; Nancy Sheets; Kevin M Miller; Joseph Horwitz; Marc Kantorow
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

4.  Down-regulation of RpS21, a putative translation initiation factor interacting with P40, produces viable minute imagos and larval lethality with overgrown hematopoietic organs and imaginal discs.

Authors:  I Török; D Herrmann-Horle; I Kiss; G Tick; G Speer; R Schmitt; B M Mechler
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Molecular characterization of the mouse ribosomal protein S24 multigene family: a uniquely expressed intron-containing gene with cell-specific expression of three alternatively spliced mRNAs.

Authors:  L Xu; G P He; A Li; H S Ro
Journal:  Nucleic Acids Res       Date:  1994-02-25       Impact factor: 16.971

6.  Ribosomal proteins and colorectal cancer.

Authors:  Mao-De Lai; Jing Xu
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

7.  Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.

Authors:  Jennifer D Hintzsche; Nicholas T Gorden; Carol M Amato; Jihye Kim; Kelsey E Wuensch; Steven E Robinson; Allison J Applegate; Kasey L Couts; Theresa M Medina; Keith R Wells; Joshua A Wisell; Martin D McCarter; Neil F Box; Yiqun G Shellman; Rene C Gonzalez; Karl D Lewis; John J Tentler; Aik Choon Tan; William A Robinson
Journal:  Melanoma Res       Date:  2017-06       Impact factor: 3.599

Review 8.  Translation initiation and its relevance in colorectal cancer.

Authors:  Emma Minnee; William James Faller
Journal:  FEBS J       Date:  2021-01-24       Impact factor: 5.622

9.  Pair-wise comparison analysis of differential expression of mRNAs in early and advanced stage primary colorectal adenocarcinomas.

Authors:  Tze Pheng Lau; April Camilla Roslani; Lay Hoong Lian; Hwa Chia Chai; Ping Chin Lee; Ida Hilmi; Khean Lee Goh; Kek Heng Chua
Journal:  BMJ Open       Date:  2014-08-08       Impact factor: 2.692

10.  Short hairpin RNA library-based functional screening identified ribosomal protein L31 that modulates prostate cancer cell growth via p53 pathway.

Authors:  Yojiro Maruyama; Toshiaki Miyazaki; Kazuhiro Ikeda; Toshiyuki Okumura; Wataru Sato; Kuniko Horie-Inoue; Koji Okamoto; Satoru Takeda; Satoshi Inoue
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.